Systematic evaluation and meta-analysis of the diagnostic accuracy of ultrasound contrast in predicting the efficacy of systemic therapy for advanced hepatocellular carcinoma

Read full text Summarise with VIRAT
Authors: Mingsheng Zhu, Hang Li, Xiaolu Liang, Zuobiao Li, Gaohui Chen, Zhijie Zhuang, Haili Huang, Wei Dai
Cited by: 0
References: 51

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Contrast-enhanced ultrasound (CEUS) is a dynamic, noninvasive imaging modality capable of real-time visualization of tumor perfusion characteristics. This systematic review and meta-analysis quantitatively evaluated the diagnostic efficacy of CEUS in predicting the response to systemic therapy in advanced hepatocellular carcinoma (HCC), aiming to validate its potential clinical value as an imaging biomarker. Methods: Databases including PubMed, Web of Science, Embase, and Cochrane Library were searched up to May 31, 2025. Diagnostic studies using modified Response Evaluation Criteria in Solid Tumors (mRECIST) or Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as reference standards were included to evaluate CEUS prediction of systemic treatment response. Two researchers independently screened literature and extracted data, assessing methodological quality using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool. Sensitivity and specificity were pooled using a bivariate random-effects model, and area under the curve (AUC) was calculated via summary receiver operating characteristic (SROC) curve plotting. Results: Five studies involving 114 HCC patients were included. The pooled sensitivity of CEUS for predicting treatment response was 0.88 [95% confidence interval (CI): 0.66-0.96], with a specificity of 0.86 (95% CI: 0.59-0.96). The SROC curve showed that CEUS demonstrated good discriminatory ability with an AUC of 0.92 (95% CI: 0.90-0.94). Spearman correlation analysis revealed no threshold effect (P≥0.05). Sensitivity analysis results were stable, with no single study significantly influencing the overall outcome. Conclusions: CEUS demonstrates promising potential in predicting the efficacy of systemic therapy for advanced HCC and serves as an effective adjunct to computed tomography (CT) or magnetic resonance imaging (MRI) in evaluating treatment response. However, due to the limited number of included studies and sample sizes, further validation of its diagnostic performance and clinical utility through large-scale, multicenter, prospective, high-quality research is still required.

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis MRI in cancer diagnosis Medical Imaging Techniques and Applications

Publication details

Journal / source
Translational Cancer Research
Volume
15
Issue
3
Pages
143–143
Publication date
1 March 2026
Language
EN